— Know what they know.
Not Investment Advice

TARO NYSE

Taro Pharmaceutical Industries Ltd.
1W: +0.5% 1M: +1.1% 3M: +1.9% 1Y: +6.1% 3Y: -41.2% 5Y: -51.4%
$42.98
Last traded 2024-06-21 — delisted
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · $1.6B mcap · 8M float · 0.458% daily turnover

📊 Key Metrics

TTM
$629M
Revenue
+9.8% YoY
$54M
Net Income
+111.7% YoY
$74M
Free Cash Flow
+523.3% YoY
53.0%
Gross Margin
5.3%
Op. Margin
9.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE3.1%
ROA2.5%
ROIC1.5%

Valuation

P/E30.1
P/B0.9
EV/EBITDA11.6

Leverage

Debt/Equity0.00
Current Ratio3.61
Interest Cov.0.0x

Quality Scores

Piotroski F9/9
Altman Z3.45
Beneish M-2.85

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms